Note 5. Segment Reporting (Segments Statements of Operations) (Details) (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011
Segment Reporting Information [Line Items]
Product revenue	$ 3,640,761	$ 3,185,932	$ 5,910,338	$ 5,592,512
Revenues, net	3,640,761	3,185,932	5,910,338	5,592,512
Cost of goods sold	1,776,054	1,461,898	2,972,452	2,686,326
Marketing, general and administrative	1,488,915	1,534,735	2,894,501	2,914,262
Research and development	266,169	210,527	530,367	430,077
Total costs and expenses	3,531,138	3,207,160	6,397,320	6,030,665
Loss from operations	109,623	(21,228)	(486,982)	(438,153)
Loss (gain) on sales of assets	2,717,069
Equity in OTM	16,842	446	81,623	1,144
Interest Expense	0	(88,059)	(92,596)	(170,550)
Total other (expense) income	16,904	(87,569)	(10,882)	(169,324)
Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest	126,527	(108,797)	(497,864)	(607,477)
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest	127,000	(110,000)
Income taxes benefit from continuing operations	0	0	0	0
Net (loss) from continuing operations	126,527	(108,797)	(497,864)	(607,477)
Income (Loss) from Continuing Operations Attributable to Parent	126,527	(108,797)
Sonomed-Escalon [Member]
Segment Reporting Information [Line Items]
Product revenue	3,640,761	3,185,932	5,910,338	5,592,512
Revenues, net	3,640,761	3,185,932	5,910,000	5,593,000
Cost of goods sold	1,776,054	1,461,898	2,972,452	2,686,326
Marketing, general and administrative	1,340,229	1,401,716	2,682,963	2,688,766
Research and development	266,169	210,527	530,367	430,077
Total costs and expenses	3,382,000	3,075,000	6,185,000	5,805,000
Loss from operations	258,309	111,791	(275,000)	(212,000)
Equity in OTM	0	0	0	0
Interest Expense	0	0	0	0
Total other (expense) income	0	0	0	0
Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest			(275,444)	(212,657)
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest	259,000	111,000
Income taxes benefit from continuing operations	0	0	0	0
Net (loss) from continuing operations			(275,444)	(212,657)
Income (Loss) from Continuing Operations Attributable to Parent	258,309	111,791
Corporate [Member]
Segment Reporting Information [Line Items]
Product revenue	0	0	0	0
Revenues, net	0	0	0	0
Cost of goods sold	0	0	0	0
Marketing, general and administrative	148,686	133,019	211,538	225,496
Research and development	0	0	0	0
Total costs and expenses	149,000	133,000	212,000	226,000
Loss from operations	(148,686)	(133,019)	(212,000)	(226,000)
Equity in OTM	17,000	0	81,623	1,144
Interest Expense	0	(88,059)	(92,596)	(170,550)
Total other (expense) income	16,904	(87,569)	(10,882)	(169,324)
Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest			(222,420)	(394,820)
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest	(132,000)	(221,000)
Income taxes benefit from continuing operations	0	0	0	0
Net (loss) from continuing operations			(222,420)	(394,820)
Income (Loss) from Continuing Operations Attributable to Parent	$ (131,782)	$ (220,588)